Cases & Deals

  • Home
  • Practices
  • Ardian develops global patent strategy for its core intraventional catheter technology

Share

Ardian develops global patent strategy for its core intraventional catheter technology

March 2009

Client(s) Ardian, Inc.

On behalf of Ardian, Inc., Jones Day has developed a global patent enforcement scheme regarding Ardian's RF ablation catheter products and method used to treat hypertension. Ardian's technology has been published in Lancet and featured in the Wall Street Journal.

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.